Creative Medical Files U.S. Provisional Patent to Expand Ultrasome™ Regenerative Medicine Platform
New filing aims to protect product composition, manufacturing methods, and therapeutic uses following promising osteoarthritis pilot results
Creative Medical Technology Holdings has submitted a U.S. provisional patent application to broaden intellectual property coverage for its Ultrasome™ cell-free regenerative platform. The filing encompasses product composition, biological potency, manufacturing controls, stability, delivery methods, and therapeutic app…